Clinical Trials in Salt Lake City

Showing 3321-3340 of 16,694 trials

Ca-Mg Butyrate in GWI

NCT05367245

The primary objective of this clinical trial is to determine if treatment with Butyrate formulation that consists of butyric acid as calcium and magnesium derivatives (Ca-Mg Butyrate) improves the physical function of men and women Veterans suffering from Gulf War Illness (GWI). The primary outcome measure is a change from baseline on the Short Form Health Survey 36-item (VSF-36), with respect to physical functioning and symptoms. The secondary outcome will focus on the drug's role in (a) restoring gut microbiome and virome, (b) decreasing gastrointestinal disturbances (constipation, diarrhea, pain), (c) decreasing chronic fatigue, (d) decreasing systemic inflammation, and (e) a decrease in cognitive deficits.

Gulf War IllnessChronic FatigueNeurocognitive Dysfunction

VA Office of Research and Development120 participantsStarted Jan 2024

Long Beach, California, United States • Miami, Florida, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

NCT05244304

The primary objective of this trial is to assesses the efficacy of tinlarebant in slowing the rate of growth of atrophic lesion(s) in adolescent subjects with STGD1

Stargardt Disease 1

Belite Bio, Inc104 participantsStarted Mar 2022

Palo Alto, California, United States • Minneapolis, Minnesota, United States • Salt Lake City, Utah, United States +16 more locations

Ca-Mg Butyrate in GWI

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

Find Trials by Condition in Salt Lake City

Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Combining a Smartphone App With Medications to Manage Heavy Drinking

Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Stress Hydrocortisone In Pediatric Septic Shock

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Clinical Validation Study of the Eximis CS (Contained Segmentation) System

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

FebriDx® Pediatric Validation Study

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)

Study Dynamic Haptic Robotic Trainer (DHRT) and DHRT+ for CVC Insertion Training for Surgical Residents

OCS Heart Perfusion Post-Approval Registry

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST